{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:21:56Z","timestamp":1791069716768,"version":"4.1.0"},"reference-count":62,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,4,4]],"date-time":"2006-04-04T00:00:00Z","timestamp":1144108800000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2006,4]]},"abstract":"<jats:p>\n                    <jats:bold>Summary:\u2002<\/jats:bold>\n                    <jats:italic>Purpose:<\/jats:italic>\n                    Stiripentol (STP) is currently an efficient drug for add\u2010on therapy in infantile epilepsies because it improves the efficacy of antiepileptic drugs (AEDs) through its potent inhibition of liver cytochromes P450. In addition, STP directly reduces seizures in several animal models of epilepsy, suggesting that it might also have anticonvulsive effects of its own. However, its underlying mechanisms of action are unknown.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Methods:<\/jats:italic>\n                    We examined the interactions of STP with \u03b3\u2010aminobutyric acid (GABA) transmission by using patch\u2010clamp methods in CA3 pyramidal neurons in the neonatal rat.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Results:<\/jats:italic>\n                    STP markedly increased miniature inhibitory postsynaptic current (mIPSC) decay\u2010time constant in a concentration\u2010dependent manner. The prolongation of mIPSC duration does not result from an interaction with GABA transporters because it persisted in the presence of GAT\u20101 inhibitors (SKF\u201089976A and NO\u2010711). An interaction with benzodiazepine or neurosteroid binding sites also was excluded because STP\u2010mediated increase of decay time was still observed when these sites were initially saturated (by clobazam, zolpidem, or pregnanolone) or blocked (by flumazenil or dehydroepiandrosterone sulfate), respectively. In contrast, saturating barbiturate sites with pentobarbital clearly occluded this effect of STP, suggesting that STP and barbiturates interact at the same locus. This was directly confirmed by using outside\u2010out patches, because STP increased the duration and not the frequency of opening of GABA\n                    <jats:sub>A<\/jats:sub>\n                    channels.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusions:<\/jats:italic>\n                    At clinically relevant concentrations, STP enhances central GABA transmission through a barbiturate\u2010like effect, suggesting that STP should possess an antiepileptic effect by itself.\n                  <\/jats:p>","DOI":"10.1111\/j.1528-1167.2006.00497.x","type":"journal-article","created":{"date-parts":[[2006,4,4]],"date-time":"2006-04-04T12:31:37Z","timestamp":1144153897000},"page":"704-716","source":"Crossref","is-referenced-by-count":134,"title":["Stiripentol, a Putative Antiepileptic Drug, Enhances the Duration of Opening of GABA\n                    <sub>A<\/sub>\n                    \u2010Receptor Channels"],"prefix":"10.1111","volume":"47","author":[{"given":"Pascale P.","family":"Quilichini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Chiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehezkel","family":"Ben\u2010Ari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Gozlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,4,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0387-7604(99)00113-8"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104123441504"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17332"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2710.1999.00201.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2003.01919.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03157-3"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420520603"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.144"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.237"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-693X(02)00090-8"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb02048.x"},{"key":"e_1_2_6_13_2","first-page":"199","article-title":"A new type of anticonvulsant, stiripentol: pharmacological profile and neurochemical study","volume":"34","author":"Poisson M","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(90)90052-W"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1985.tb05715.x"},{"key":"e_1_2_6_16_2","first-page":"455","article-title":"[Pharmaco\u2010cellular enzymology of the mechanism of action of stiripentol in cardiazol\u2010induced epilepsy, III: protein, nucleoprotein, lipid, and proteoglycan metabolism]","volume":"23","author":"Wegmann R","year":"1978","journal-title":"Cell Mol Biol"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050147"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1993.tb02416.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(92)90764-X"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(94)90089-2"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90804-D"},{"key":"e_1_2_6_22_2","first-page":"207","article-title":"Cloning of the human homologue of the GABA transporter GAT\u20103 and identification of a novel inhibitor with selectivity for this site","volume":"2","author":"Borden LA","year":"1994","journal-title":"Receptor Channels"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.04.025"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(93)90308-E"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1996.76.6.3983"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1287-04.2004"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200106130-00016"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1996.tb00643.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(03)00270-3"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-13-05119.1997"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2003.02597.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1998.80.4.1670"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(92)90073-B"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2003.059246"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1703"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2003.09.001"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(00)89058-6"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(03)00251-X"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(99)01381-5"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0634"},{"key":"e_1_2_6_41_2","first-page":"1227","article-title":"Potentiation of gamma\u2010aminobutyric acid type A receptor\u2010mediated synaptic currents by pentobarbital and diazepam in immature hippocampal CA1 neurons","volume":"266","author":"Zhang L","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-3806(99)00022-X"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2003.09.025"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00710-4"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1996.sp021784"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15221.x"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.58.3.463"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.1998.643bd.x"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(93)90503-8"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90910-4"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410250302"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb02454.x"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1952.sp004735"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2004.03.007"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00169293"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1988.tb02486.x"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00502574"},{"key":"e_1_2_6_58_2","first-page":"165","article-title":"[Neurophysiological and therapeutic evaluation of stiripentol in epilepsy: preliminary results]","volume":"144","author":"Loiseau P","year":"1988","journal-title":"Rev Neurol (Paris)"},{"key":"e_1_2_6_59_2","article-title":"Stiripentol in childhood partial epilepsy: a randomized placebo\u2010controlled trial with enrichment and withdrawal design","author":"Chiron C","year":"2006","journal-title":"J Child Neurol"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200115050-00001"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.042suppl.3008.x"},{"key":"e_1_2_6_62_2","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0022-3565(24)35017-7","article-title":"Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine\u2010induced seizures","volume":"290","author":"Gasior M","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(81)91179-3"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1528-1167.2006.00497.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1528-1167.2006.00497.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T01:45:00Z","timestamp":1736300700000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1528-1167.2006.00497.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["10.1111\/j.1528-1167.2006.00497.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1528-1167.2006.00497.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}